- Home
- ALGS vs EKSO Comparison
ALGS vs EKSO Comparison
Compare ALGS & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | EKSO |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9M | 37.9M |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ALGS | EKSO |
|---|---|---|
| Price | $5.71 | $11.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $39.33 | $9.50 |
| AVG Volume (30 Days) | ★ 227.8K | 36.4K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | 41.76 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $32.20 | $81.23 |
| Revenue Next Year | $4.71 | $7.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.12 | $0.23 |
| 52 Week High | $13.69 | $13.50 |
Technical Indicators
Market Signals| Indicator | ALGS | EKSO |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 60.17 |
| Support Level | N/A | $8.30 |
| Resistance Level | $6.76 | $12.39 |
| Average True Range (ATR) | 0.50 | 0.86 |
| MACD | 0.02 | 0.15 |
| Stochastic Oscillator | 5.56 | 79.44 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.